• No results found

[PDF] Top 20 . Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix F - Bowel Cancer.

Has 10000 ". Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix F - Bowel Cancer." found on our website. Below are the top 20 most common ". Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix F - Bowel Cancer.".

. Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Program

. Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix F - Bowel Cancer.

... not reported by the original review ...both cancer specific and generic measures, whilst in others it was unable to detect differences between groups where condition specific measures (EORTC ... See full document

36

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix J - Dementia.

... these measures are not preference-based and cannot be used to generate quality adjusted life years (QALYs) in economic ...preference-based measures, the DEMQOL-U and the DEMQOL-U-proxy, that ... See full document

44

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix K - Cardiovascular.

... the audit fields in general have relatively high completion rates, with the exception of HRQoL, the information currently collected in the existing NACSA would provide a considerable amount of the information ... See full document

112

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix H - Psychological Therapies

... was reported to be good, though data from one study showed that the EQ-5D correlated better with depression-specific measures and subscales than with anxiety-specific ones in people with ...validation ... See full document

49

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix G - Head and Neck Cancer.

... neck cancer demonstrated that there were substantial gaps in the evidence base used to assign HRQoL scores along the clinical pathway for patients with head and neck ...data used in these TAs ... See full document

19

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix I - Schizophrenia

... and clinical benefits ...be used to inform the HRQoL associated with the condition or the interventions ...and patient responses to the clinical audits, together with the inclusion of a ... See full document

42

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix D - Epilepsy

... studies reported results that provide some support for the construct validity of the ...(MOS) measures (EQ-5D: ...al. used the national hospital seizure severity score (NHSSS) to measure ... See full document

54

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme.

... base assessing the psychometric properties of the EQ-5D in adults with epilepsy on the whole is positive albeit ...generic measures (SF-6D and health utility index ...the National hospital seizure ... See full document

82

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix E - Diabetes

... diabetes audits would be useful for gaps in the evidence base such as HRQoL associated with hypoglyceamic events and ...variable used should be selected on the basis that it could ultimately be ... See full document

57

Supporting the collection patient reported outcome measures in the National Clinical Audits for assessing costeffectiveness Work Package 1. What patient reported outcome measures should be used in the 13 health conditions specified in the 2013/14 National

Supporting the collection patient reported outcome measures in the National Clinical Audits for assessing costeffectiveness Work Package 1. What patient reported outcome measures should be used in the 13 health conditions specified in the 2013/14 National Clinical Audit programme? APPENDIX C, INFLAMMATORY BOWEL DISEASE

... arthritis, cancer, cardiac disease, diabetes) which are designed to be used in conjunction with the core ...when used in conjunction with the core PedsQL ... See full document

59

Patient reported outcome measures for use in pregnancy and childbirth: a systematic review

Patient reported outcome measures for use in pregnancy and childbirth: a systematic review

... process used the Edinburgh Postnatal Depression Scale (EPDS) as an initial screening tool, followed by the administra- tion of the Patient Health Questionnaire-9 (PHQ-9) and physician evaluation for those ... See full document

8

Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy? The Experience of the Standardisation of Breast Radiotherapy (START) Trials in Early Breast Cancer.

Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy? The Experience of the Standardisation of Breast Radiotherapy (START) Trials in Early Breast Cancer.

... PROPROMs, clinical and photographic assessments at each time point and compared on an individual patient basis using measures of concordance including percentage agreement (with 95% confidence ... See full document

68

Psychometric validation of patient-reported outcome measures assessing chronic constipation

Psychometric validation of patient-reported outcome measures assessing chronic constipation

... some bowel symptoms were highly ...of measures should be allowed to ...PRO measures are more correlated with each other than can be explained by the variance shared with the ... See full document

10

Interpreting the results of patient reported outcome measures in clinical trials: The clinician's perspective

Interpreting the results of patient reported outcome measures in clinical trials: The clinician's perspective

... This figure shows the results of a hypothetical trial that compares the effects size after an effective intervention in a treatment group (T) to a control group (C) after an effective intervention. The treatment group ... See full document

8

Value of the Routine Assessment of Patient Index Data 3 in Patients With Psoriatic Arthritis: Results From a Tight‐Control Clinical Trial and an Observational Cohort

Value of the Routine Assessment of Patient Index Data 3 in Patients With Psoriatic Arthritis: Results From a Tight‐Control Clinical Trial and an Observational Cohort

... of patient index data 3 (RAPID3) is an index composed of only the 3 patient self-reported measures from the rheumatoid arthritis (RA) Core Data Set(3): physical function on a health assessment ... See full document

26

An alternative approach to implementing patient-reported outcome measures

An alternative approach to implementing patient-reported outcome measures

... a clinical service proved a management ...support clinical and other decisions. The various clinical groups in the case study with few excep- tions resorted to traditional methods of data ... See full document

9

Chiropractors’ views on the use of patient-reported outcome measures in clinical practice: a qualitative study

Chiropractors’ views on the use of patient-reported outcome measures in clinical practice: a qualitative study

... The qualitative interviews identified that chiropractors often had a lack of knowledge and engagement with PROMs, despite using them in clinical practice. It is also acknowledged in the findings that ... See full document

9

Patient involvement in the development of patient reported outcome measures: The developers’ perspective

Patient involvement in the development of patient reported outcome measures: The developers’ perspective

... of patient involvement and practical solutions should certainly not be completely disregarded as it helps developers involve patients within their ...a patient during ...on what is most ... See full document

10

<p>PROMs data: can it be used to make decisions for individual patients? A narrative review</p>

<p>PROMs data: can it be used to make decisions for individual patients? A narrative review</p>

... and cost of health care rise, it is argued that it is value, rather than the amount of care, which is considered most ...the cost of achieving those outcomes is considered fundamental in ...this. ... See full document

9

Assessment of patient-reported outcome measures in pleural interventions

Assessment of patient-reported outcome measures in pleural interventions

... There are limitations to this work. Patients were assessed from one hospital which is a tertiary referral centre for pleural disease. This study only assessed symptom change at 1 hour post procedure for ... See full document

6

Show all 10000 documents...